LEADER 01826nam  2200481   450 
001 9910148726703321
005 20110513082941.0
010   $a1-61728-643-5
035   $a(CKB)3710000000922274
035   $a(MiAaPQ)EBC4743800
035   $a(EXLCZ)993710000000922274
100   $a20100419h20112011  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aSignificance of free radical-modified fibrinogen in thrombosis and related diseases /$fBoguslaw Lipinski
210  1$aHauppauge, New York :$cNova Science Publishers,$d[2011]
210  4$dİ2011
215   $a1 online resource (97 pages) $cillustrations
225 1 $aCardiology research and clinical developments
311   $a1-61668-859-9 
320   $aIncludes bibliographical references and index.
327   $aProperties and functions of fibrinogen -- Fibrin and fibrinolysis -- Oxidative stress versus free radical stress -- Hydroxyl radical-induced modification of human fibrinogen -- Hydroxyl radical-modified fibrinogen in various pathologic conditions.
410  0$aCardiology research and clinical developments series.
606   $aThrombosis
606   $aFibrinogen
606   $aBlood coagulation disorders
606   $aFree radicals (Chemistry)$xPathophysiology
615  0$aThrombosis.
615  0$aFibrinogen.
615  0$aBlood coagulation disorders.
615  0$aFree radicals (Chemistry)$xPathophysiology.
676   $a616.1/35
700   $aLipinski$b Boguslaw$f1933-$01236542
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910148726703321
996   $aSignificance of free radical-modified fibrinogen in thrombosis and related diseases$92871168
997   $aUNINA